Cancer-Testis Antigens in Triple-Negative Breast Cancer: Role and Potential Utility in Clinical Practice

SIMPLE SUMMARY: Triple-negative breast cancer (TNBC) has been associated with worse prognoses due to the limited treatment options. Thus, there is a need to characterise new biomarkers or treatment targets to improve patient outcomes. Cancer testis antigens (CTAs) are a group of antigens that are pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Runyi Adeline, Tien, Tracy Zhijun, Joseph, Craig Ryan, Lim, Johnathan Xiande, Thike, Aye Aye, Iqbal, Jabed, Tan, Puay Hoon, Yeong, Joe Poh Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345750/
https://www.ncbi.nlm.nih.gov/pubmed/34359776
http://dx.doi.org/10.3390/cancers13153875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345750/
https://www.ncbi.nlm.nih.gov/pubmed/34359776
http://dx.doi.org/10.3390/cancers13153875

Ejemplares similares